$67.550
+0.757 (+1.12%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PCVX Prediction & Forecast by Similar Chart Analysis
Alphio's PCVX stock price prediction model matches the current Vaxcyte Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $68.02 (+0.70%). The 1-week path is $61.25 (-9.33%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Vaxcyte Inc Stock?
Vaxcyte Inc is a good buy right now due to its recent positive Phase 3 trial results for its pneumococcal vaccine, which led to a 60% stock surge, pushing the current price to $71.38. Analysts have set price targets as high as $163, indicating significant upside potential. However, the company is facing substantial net losses, with a projected EPS of -2.30 for Q1 2026, which remains a key risk.
PCVX stock price ended at $67.55 on Wednesday, after rising +1.12%
Vaxcyte Inc (PCVX) last closed at $67.55, gaining +1.12%. These facts feed the 1-day and 1-week PCVX price prediction above.
Forecast Drivers
Vaxcyte Inc (PCVX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches PCVX, ranked by similarity.
Seasonality analysis for PCVX
Historically the probability of a positive October return for PCVX is 59.65%. February offers the highest probability of a positive month at 86.21%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PCVX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $27.34 | $32.32 | $36.02 | -52.16% |
| Nov 2026 | $37.97 | $42.65 | $49.56 | -36.86% |
| Dec 2026 | $39.67 | $40.50 | $43.09 | -40.04% |
In 2026, Vaxcyte Inc (PCVX) is projected to range from $27.34 to $49.56.
Vaxcyte Inc 2026 monthly forecast
In Oct 2026, Vaxcyte Inc is projected to average $32.32, with a low of $27.34 and high of $36.02.
In Nov 2026, Vaxcyte Inc is projected to average $42.65, with a low of $37.97 and high of $49.56.
In Dec 2026, Vaxcyte Inc is projected to average $40.50, with a low of $39.67 and high of $43.09.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.